Preview

Russian journal of hematology and transfusiology

Advanced search

PRODUCTION OF PURIFIED FIBRINOGEN CONCENTRATE

https://doi.org/10.35754/0234-5730-2019-64-1-73-78

Abstract

Aim. To present a technique for obtaining fibrinogen concentrate purified from ballast proteins, which can be used in hemostatic drug production.

Materials and methods. The proposed method is based on isolating fibrinogen from a cryoprecipitate solution by its precipitation with a polyethylene glycol solution followed by virus inactivation by a solvent/detergent. Purification from viral inactivation products and ballast proteins is performed by a two-step processing of the obtained fibrinogen concentrate with glycine solution.

Results. The developed laboratory method for isolating fibrinogen has been optimized in terms of main parameters and scaled in pilot production.

Conclusion. The presented laboratory technique for fibrinogen extraction is characterized by a high yield of the target product, thus being suitable for the production of hemostatic drugs.

About the Authors

V. V. Khurdin
MIREA-Russian Technological University
Russian Federation
Vyacheslav V. Khurdin*, Postgraduate Researcher, Department of Biotechnology and Industrial Pharmacy


A. L. Berkovskiy
National Medical Research Center for Hematology
Russian Federation
Aron L. Berkovsky, Cand. Sci. (Med.), Consultant


E. V. Sergeeva
NPO Renam “Society of Hemophilia Patients”
Russian Federation
Elena V. Sergeeva, Production Manager


A. V. Suvorov
NPO Renam “Society of Hemophilia Patients”
Russian Federation
Alexander V. Suvorov, Cand. Sci. (Biol.), Senior Researcher


References

1. Redman C., Xia H. Fibrinogen biosynthesis. Ann N Y Acad Sci. 2001; 936: 480–95.

2. Kozlov A.A., Berkovskij A.L., Kachalova N.D., et al. The manual for laboratory assistant on methods of studying plasma hemostasis. Coagulation factors. Moscow: Renam; 2008 (In Russian).

3. Bratchik A.M. Clinical problems of fibrinolysis. Kiev; 1993 (In Russian).

4. Zubairov D.M. Molecular basis of blood clotting and thrombus formation. Kazan; 2000 (In Russian).

5. Mosesson M.W. Fibrnogen and fibrin structure and functions. J Thromb Haemost. 2005; 3: 1894–904.

6. Krajnova T.A., Piskareva Yu.K., Anastasiev V.V. Blood medicine. Instructive and methodological materials for control and production. Мoscow; 1976 (In Russian).

7. Instruction for conducting donor intermittent plasmapheresis. The Ministry of Health of Russia, 23.09.2002 (In Russian).

8. Technical Regulations on blood safety requirements, its products, blood-substituting solutions and technical equipment used in transfusion-infusion therapy. Approved RF Government Decree of 26 January. 2010, № 29 (In Russian).

9. Billy D., Speijer H., Zwaal R.F.A., et al. Anticoagulant and membrane-degrading effects of secretory (non-pancreatic) phospholipase A2, are inhibited in plasma. Thromb. Haemost. 2002; 87: 978–84.

10. Yermolenko I.S., Lishko V.K., Ugarova T.P., Magonov S.N. High-resolution visualization of fibrinogen molecules and fibrin fibers with atomic force microscopy. Biomacromolecules. 2011; 12: 70–9.

11. Brown J.H., Volkmann N., Jun G., et al. The crystal structure of modified bovine fibrinogen. Proc Natl Acad Sci USA. 2000; 97: 85–90.

12. Brown A.E., Litvinov R.I., Discher D.E., Weisel J.W. Forced unfolding of coiledcoils in fibrinogen by single-molecule AFM. Biophys J. 2007; 92: 39–41.

13. Brown A.E., Litvinov R.I., Discher D.E., et al. Multi-scale mechanics of fibrin polymer: gel stretching with protein unfolding and loss of water. Science. 2009; 325: 741–4.


Review

For citations:


Khurdin V.V., Berkovskiy A.L., Sergeeva E.V., Suvorov A.V. PRODUCTION OF PURIFIED FIBRINOGEN CONCENTRATE. Russian journal of hematology and transfusiology. 2019;64(1):73-78. (In Russ.) https://doi.org/10.35754/0234-5730-2019-64-1-73-78

Views: 4610


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0234-5730 (Print)
ISSN 2411-3042 (Online)